Prevalence of hospital acquired enterococci infections in two primary-care hospitals in Osogbo, Southwestern Nigeria

Enterococci are opportunistic bacteria that become pathogenic when they colonize niches where they are not normally found. Of recent, they have become major cause of nosocomial infections, especially of the bloodstream, urinary tract and surgical sites. The aim of this study is to determine the point‐prevalence rate of human enterococci infections among hospitalized patients in Osogbo, Nigeria. The study was conducted between January and June 2009 in two primary‐care hospitals in Osogbo and involved a total of 118 patients who developed clinical evidence of infection at least 48 hours after hospital admission. Appropriate clinical samples were collected from the patients after an informed consent and cultured for isolation/biochemical identification of Enterococcus species at the Bacteriology Laboratory of Ladoke Akintola University of Technology, Osogbo using standard microbiological methods. There were 525 hospital admissions within the time frame of the study of which 118 (22.5%) developed hospital acquired infection (HAI); 58 (49.2%) of which cultured positive for bacterial pathogens. Enterococci were isolated from infective focus in 7 patients, giving a prevalence rate of hospital‐acquired enterococci infection of 5.9%. Two species of Enterococcus were identified; Enterococcus faecalis from urinary tract infection (UTI) and surgical site infection (SSI) of 6 (85.7%) patients and Enterococcus faecium from UTI in 1 (14.3%) patient. Other bacteria recovered from other infective foci were Klebsiella spp 31.0%, Pseudomonas spp 20.7%, Staphylococcus aureus 17.2%, Escherichia coli 12.1%, Staphylococcus epidermidis 3.4%, Streptococcus pneumoniae 1.7% and Serratia spp 1.7%. All the enterococci isolates were multiply antibiotic resistant, and 42.9% were vancomycin‐resistant enterococci (VRE) with the VRE strains showing resistance to wider range of antibiotics than the vancomycin‐sensitive strains. Other Gram‐positive and Gram negative bacterial isolates also demonstrated multiple resistance to all commonly available antibiotics in this community except E. coli and Pseudomonas spp which were relatively sensitive to ciprofloxacin and ceftazidime. This limited study demonstrated a high prevalence rate of multiple antibiotic resistant enterococci infections among hospitalized patients in this environment. There is need for systematic surveillance of hospitals for enterococci infections; prudent use and rational prescription of antibiotics and stringent measures to reduce the prevalence rate by health education on infection control measures such asisolation, cleaning, disinfection and sterilization.Keywords: Nosocomial, Prevalence, Enterococcus, Vancomycin‐Resistance, Primary Car

Adsorptive removal of various phenols from water by South African coal fly ash

South African coal fly ash (SACFA) was used to effectively remove phenol, 2-nitrophenol and 4-nitrophenol from wastewater. The rate of adsorption follows first-order kinetics before attaining equilibrium with the sorption rate (Kad) obtained being the  highest for 4-nitrophenol (p-nitrophenol) (7.0 x 10.3/h), followed by phenol (1.2 x 10.3/h) and 2-nitrophenol (o-nitrophenol) (1.0 x 10.3/h). Batch studies were performed to evaluate the adsorption process, and it was found that the Freundlich isothermeffectively fits the experimental data for the adsorbates better than the Langmuir model, with the fly ash having the highest adsorption capacity of 6.51 X 10-2 mg/g for 4-nitrophenol, 6.00 x 10-2 mg/g for 2-nitrophenol and 6.31 x10-2 mg/g for phenol. The fly ash was found to adsorb 90.2% of phenol, 88.9% of 2-nitrophenol and 92.6% of 4-nitrophenol at an initialconcentration of 20 mg/.. The desorption studies suggested that the desorption of 4-nitrophenol was the most difficult of the three adsorbates to be desorbed. The desorption efficiency was 17.9% for phenol, 18.8% for 2-nitrophenol and 10.2% for 4-nitrophenol. This work proved that SACFA can be used as an efficient adsorbent material for removal of phenol from water and wastewater

Transgenic cassava lines carrying heterologous alternative oxidase (AtAOX1a) showed impaired quantitative and qualitative response to embryogenesis

In our approach to control reactive oxygen species produced as a result of oxidative stress experienced by cassava roots during harvesting, a phenomena which causes postharvest physiological deterioration in the roots, we transformed cassava variety TMS 60444 with the AtAOX1a gene, driven by the 35S promoter, using agrobacterium-mediated approach. Extracted genomic DNAs of putative transgenic lines were screened using polymerase chain reaction technique (PCR). Messenger RNA was extracted from selected PCR-positive lines for reverse transcription-PCR analysis for gene expression. To screen positive lines for gene function, leaf lobes from two transgenic lines with a line carrying an empty vector and the wild type were subjected to somatic embryogenesis (SE), a known oxidative stress process. The results show that the wild type, at 16 days after initiation (DAI) of the leaf lobes on callus initiation medium, had the highest (100%) number of leaf lobes that produced at least one observed organised embryogenic structure (OES). This was followed by PEV-3, the empty vector plant with 50% OES production, while PB-3 had the least percent (20%) of leaf lobes with OES. PB-3 line also had no OES at all in five out of the seven periods of data collection. During the period, the wild type recorded the highest attainable OES quality score of 2.0 (on a scale of 1-5 where 1=bad and 5=excellent) at the first initiation cycle. Both the transgenic lines and the empty-vector plantlet recorded quality score of 1.0. It seems AtAOX1a only hinders OES development, but exerts little effect on the quality, if OES does not degenerate after development.Keywords: Genomic DNAs, reverse transcription-PCR, somatic embryogenesis (SE)African Journal of Biotechnology Vol. 12(27), pp. 4303-430

Patient complexity and genotype-phenotype correlations in biliary atresia: a cross-sectional analysis

published_or_final_versio

Crystallization and preliminary X-ray crystallographic analysis of a yedU gene product from Escherichia coli

A yedU gene product with a molecular mass of 31 kDa is a hypothetical protein with no known function. The protein was purified and crystallized at 296 K. X-ray diffraction data have been collected to 2.3 Angstrom using synchrotron radiation. The crystals belong to the primitive orthorhombic system, with unit-cell parameters a = 50.56, b = 63.45, c = 168.02 Angstrom. The asymmetric unit contains two monomers of the protein, with a corresponding V-M of 2.25 Angstrom(3) Da(-1) and a solvent content of 44.84%.open2

Mycotoxin Zearalenone induced apoptosis in BEAS-2B cells through generation of ROS and activation of JNK and p38 MAPKs signalling pathways

Session: ET05P - Ecotoxicology and ecosystem services: A southern perspective: WE 304Human exposure to Zearalenone (ZEA, a non-steroidal estrogenic mycotoxin) through inhalation has raised considerable concern. However, the potential health risk and the mechanism of actions of ZEA are not well understood. In the present study, we used BEAS-2B, cultured human bronchial epithelial cells, as well as Cygb stably transfected BEAS-2B cells to study the cytotoxic effects and the toxic mechanisms of ZEA. Our results indicated that ZEA decreased cell viability, induced apoptosis and promoted ROS level in BEAS-2B cells. Oxidative stress was clearly evident, as shown by an elevated mRNA expression levels of oxidative stress markers (Hsp70 and Hsp27) and endogenous antioxidants (SOD2 and Gpx). Stable transfection of Cygb significantly increased the level of Cygb but reduced level of ROS and the percentage of apoptotic cells induced by ZEA. Cells pretreated with either p38 or JNK inhibitors showed no attenuation in ROS level, but the percentage of apoptotic cells was lower than cells treated with ZEApostprin

A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis

published_or_final_versio

Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial

BACKGROUND: The efficacy of seasonal influenza vaccination against 2009 pandemic influenza A(H1N1) remains unclear. METHODS: One child aged 6-17 years in each of 796 households was randomized to receive 2009-2010 seasonal trivalent inactivated influenza vaccine (TIV) or saline placebo between August 2009 and February 2010. Households were followed up with serology, symptom diaries, and collection of respiratory specimens during illnesses. The primary outcomes were influenza infection confirmed by reverse-transcription polymerase chain reaction (RT-PCR) or a >/=4-fold rise in serum antibody titer measured by hemagglutination inhibition assay. RESULTS: Receipt of TIV led to 8-13-fold mean geometric rises in antibody titers against seasonal A and B viruses, but only 1.5-fold mean geometric rises against the pandemic A(H1N1) virus that was not included in the vaccine. Children who received TIV had a reduced risk of seasonal influenza B confirmed by RT-PCR, with a vaccine efficacy estimate of 66% (95% confidence interval [CI], 31%-83%). Children who received TIV also a had reduced risk of pandemic influenza A(H1N1) indicated by serology, with a vaccine efficacy estimate of 47% (95% CI, 15%-67%). CONCLUSIONS: Seasonal TIV prevented pandemic influenza A(H1N1) and influenza B infections in children. Pandemic A(H1N1) circulated at the time of vaccination and for a short time afterward with no substantial seasonal influenza activity during that period. The potential mechanism for seasonal TIV to provide protection, possibly short lived, for children against pandemic A(H1N1) infection despite poor cross-reactive serologic response deserves further investigation. Clinical Trials Registration. NCT00792051.postprin

Correlates of Complete Childhood Vaccination in East African Countries.

Despite the benefits of childhood vaccinations, vaccination rates in low-income countries (LICs) vary widely. Increasing coverage of vaccines to 90% in the poorest countries over the next 10 years has been estimated to prevent 426 million cases of illness and avert nearly 6.4 million childhood deaths worldwide. Consequently, we sought to provide a comprehensive examination of contemporary vaccination patterns in East Africa and to identify common and country-specific barriers to complete childhood vaccination. Using data from the Demographic and Health Surveys (DHS) for Burundi, Ethiopia, Kenya, Rwanda, Tanzania, and Uganda, we looked at the prevalence of complete vaccination for polio, measles, Bacillus Calmette-Guérin (BCG) and DTwPHibHep (DTP) as recommended by the WHO among children ages 12 to 23 months. We conducted multivariable logistic regression within each country to estimate associations between complete vaccination status and health care access and sociodemographic variables using backwards stepwise regression. Vaccination varied significantly by country. In all countries, the majority of children received at least one dose of a WHO recommended vaccine; however, in Ethiopia, Tanzania, and Uganda less than 50% of children received a complete schedule of recommended vaccines. Being delivered in a public or private institution compared with being delivered at home was associated with increased odds of complete vaccination status. Sociodemographic covariates were not consistently associated with complete vaccination status across countries. Although no consistent set of predictors accounted for complete vaccination status, we observed differences based on region and the location of delivery. These differences point to the need to examine the historical, political, and economic context of each country in order to maximize vaccination coverage. Vaccination against these childhood diseases is a critical step towards reaching the Millennium Development Goal of reducing under-five mortality by two-thirds by 2015 and thus should be a global priority